5-Hydroxyanthranilic acid structure
|
Common Name | 5-Hydroxyanthranilic acid | ||
|---|---|---|---|---|
| CAS Number | 394-31-0 | Molecular Weight | 153.14 | |
| Density | 1.491 g/cm3 | Boiling Point | 417.8ºC at 760 mmHg | |
| Molecular Formula | C7H7NO3 | Melting Point | 247 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | 206.5ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 5-Hydroxyanthranilic acid2-Amino-5-hydroxybenzoic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | 5-Hydroxyanthranilic acid |
|---|---|
| Synonym | More Synonyms |
| Description | 2-Amino-5-hydroxybenzoic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog | |
| In Vitro | Diabeton 是一种磺酰脲类降血糖药,口服用于治疗非胰岛素依赖型糖尿病。当这种改变本身未被证明有效时,它用于通过饮食改变来补充治疗。它的作用持续时间为12小时或更长时间。老年患者可用糖尿病代替氯磺丙脲。 |
| Density | 1.491 g/cm3 |
|---|---|
| Boiling Point | 417.8ºC at 760 mmHg |
| Melting Point | 247 °C (dec.)(lit.) |
| Molecular Formula | C7H7NO3 |
| Molecular Weight | 153.14 |
| Flash Point | 206.5ºC |
| Exact Mass | 153.04300 |
| PSA | 83.55000 |
| LogP | 1.25380 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R20/22;R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2918290000 |
| Precursor 8 | |
|---|---|
| DownStream 10 | |
| HS Code | 2922509090 |
|---|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Chromatographic evaluation and QSAR optimization for benzoic acid analogues against carbonic anhydrase III.
J. Enzyme Inhib. Med. Chem. 30 , 420-9, (2015) An HPLC-size exclusion method was developed as an assay method to evaluate the binding of tested compounds with carbonic anhydrase III (CAIII) enzyme. Inhibition of CAIII by a group of benzoic acid an... |
|
|
[The effect of diabeton and metformin on the free-radical oxidation processes and the structural characteristics of the phospholipid composition of the erythrocyte membranes in non-insulin-dependent diabetes mellitus].
Sov. Med. (7) , 14-6, (1991) Newly detected noninsulin--dependent diabetes mellitus is shown to have changes in phospholipid structure of erythrocytic membranes: a fall in total phospholipids, sphingomyelin, phosphatidylcholine, ... |
|
|
[The efficacy of the antiaggregants ticlid and diabeton in correcting chronic intravascular microcoagulation of the blood in diabetic patients].
Ter. Arkh. 63(10) , 44-9, (1991) Hemocoagulation was examined in 477 diabetes mellitus patients. Whatever the disease type, severity, duration and the intensity of microvascular complications, diabetes mellitus was discovered to be m... |
| 5-Hydroxyanthranilic |
| 5-hydroxy-2-aminobenzoic acid |
| 2-Amino-5-Hydroxybenzoic |
| 5-hydroxy-2-anthranilic acid |
| diabeton |
| 5-HYDROXYANTHRANILLIC ACID |
| MFCD00007870 |
| 4-aminophenol-2-carboxylic acid |
| 2-AMINO-5-HYDROXYBENZOIC ACID |
| Glyklaside |
| Hydroxyanthranilic acid |